Fluidx Medical Technology, Inc.

This study tests a new device called GPX® Embolic Device for blocking blood flow to tumors and other areas in the body. About 114 adults who need this procedure will take part. The goal is to see if the device is safe and works well at reaching and blocking small blood vessels.